Clostridium difficile – o bacterie „ucigașă” existentă în flora normală a intestinului - Synevo
Clostridium Difficile Toxoid A - The Native Antigen Company
Test restrictions more effective than EHR-based support at reducing C. difficile testing
Oral Microbiome Therapy for Recurrent <i>C. difficile</i> Infection | NEJM
Recurrent Clostridioides difficile infection: Recognition, management, prevention | Cleveland Clinic Journal of Medicine
Exploring Novel Therapeutics for C. difficile During the C. difficile Awareness Month — Biotia
Clostridium Difficile: An Intestinal Infection on the Rise - Harvard Health Publishing - Harvard Health
Health: Epidemiology Resource Center: Clostridioides difficile
A Revised Understanding of Clostridioides difficile Spore Germination: Trends in Microbiology
C. diff Infections | C. difficile | MedlinePlus
Study reveals how C. difficile disrupts the gut
Clostridium difficile | FOAMid
Microbiologic factors affecting Clostridium difficile recurrence - ScienceDirect
Clostridium Difficile Toxin B - The Native Antigen Company
Why is C. difficile infection so challenging to control? - PDI Healthcare
Reduction in Health Care Facility–Onset Clostridioides difficile Infection: A Quality Improvement Initiative - Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Cureus | Do Probiotics Prevent Clostridium difficile-Associated Diarrhea?
Clostridioides difficile Infection | HAI | CDC
Clostridium difficile infection | Nature Reviews Disease Primers
Infectia cu Clostridium difficile - Analize medicale recomandate | Bioclinica
